BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21266938)

  • 1. Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; Del Castillo F; Hernández-Sampelayo T; Bueno M; Calvo C; Ríos E; Méndez C;
    Pediatr Infect Dis J; 2011 Jun; 30(6):471-4. PubMed ID: 21266938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.
    Obando I; Camacho-Lovillo MS; Porras A; Gandía-González MA; Molinos A; Vazquez-Barba I; Morillo-Gutierrez B; Neth OW; Tarrago D
    Clin Microbiol Infect; 2012 Aug; 18(8):763-8. PubMed ID: 21910779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Clin Vaccine Immunol; 2013 Oct; 20(10):1524-30. PubMed ID: 23925887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
    Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
    Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
    Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
    Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; Del Castillo F; Hernández-Sampelayo T; Otheo E; Balboa F; Ríos E; Méndez C;
    Clin Vaccine Immunol; 2011 Jan; 18(1):89-94. PubMed ID: 21047996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of pneumococcal empyema in adults in the early 21st century.
    Burgos J; Lujan M; Falcó V; Sánchez A; Puig M; Borrego A; Fontanals D; Planes AM; Pahissa A; Rello J
    Clin Infect Dis; 2011 Aug; 53(3):254-61. PubMed ID: 21765073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine.
    de Sevilla MF; García-García JJ; Esteva C; Moraga F; Hernández S; Selva L; Coll F; Ciruela P; Planes AM; Codina G; Salleras L; Jordan I; Domínguez A; Muñoz-Almagro C
    Pediatr Infect Dis J; 2012 Feb; 31(2):124-8. PubMed ID: 22173137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
    Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
    Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal disease: emergence of serotypes 19A and 7F following conjugate pneumococcal vaccination in a Mexican hospital.
    Chacon-Cruz E; Velazco-Mendez Y; Navarro-Alvarez S; Rivas-Landeros RM; Volker ML; Lopez-Espinoza G
    J Infect Dev Ctries; 2012 Jun; 6(6):516-20. PubMed ID: 22706195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
    Long SS
    Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
    [No Abstract]   [Full Text] [Related]  

  • 13. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
    Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine.
    Calbo E; Díaz A; Cañadell E; Fábrega J; Uriz S; Xercavins M; Morera MA; Cuchi E; Rodríguez-Carballeira M; Garau J;
    Clin Microbiol Infect; 2006 Sep; 12(9):867-72. PubMed ID: 16882291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine.
    Syrogiannopoulos GA; Michoula AN; Tsimitselis G; Vassiou K; Chryssanthopoulou DC; Grivea IN
    Infect Dis (Lond); 2016 Oct; 48(10):749-53. PubMed ID: 27320108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
    Moraga-Llop FA
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
    [No Abstract]   [Full Text] [Related]  

  • 18. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
    Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
    J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiplex polymerase chain reaction method for rapid pneumococcal serotype determination in childhood empyema.
    Maataoui N; Bidet P; Doit C; De Lauzanne A; Lorrot M; Mariani-Kurkdjian P; Faye A; Bingen E
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):245-9. PubMed ID: 21353946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.